CENTESSA PHARMACEUTICALS-ADR (CNTA) Institutional Ownership

CNTA is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $7.35M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $7.35M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's CNTA position is now estimated to be worth approximately $7.38M, representing an estimated gain of +0.38% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward CENTESSA PHARMACEUTICALS-ADR (CNTA).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20261$7,348,200185,000
Q4 20251$6,985,293279,300
Q3 20251$3,991,550164,600
Q2 20251$5,057,586384,900
Q1 20251$2,559,640178,000
Q4 20241$2,991,550178,600
Q3 20241$3,351,504209,600
Q2 20241$1,568,511173,700
Q1 20241$2,472218,800
Q4 20231$1,477185,600
Q3 20231$34453,100
Q2 20231$21234,300

Related CNTA Institutional Insights: